ALVO · Alvotech
$4.06
-0.04 (-0.86%)
At close · Aug 14
Market Cap
$1.37B
Shares
338.22M
Alvotech Earnings Call Transcripts
Every quarterly earnings call for Alvotech (ALVO) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Earnings call
FY26 · Q4
2027-03-11
Q4 2026 Earnings Call (Full Year)
Scheduled
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY26 · Q3
2026-11-12
Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-08-20
Q2 2026 Earnings Call
Scheduled
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-08
Goldman Sachs 47th Annual Global Healthcare Conference Miami 2026
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-04
Jefferies Global Healthcare Conference New York 2026
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-03-31
Alvotech Q1 FY2026 Earnings Call
Positive tone
Pipeline submissions and approvals
FDA inspection and BLA resubmissions
Geographic expansion
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Alvotech Q3 FY2025 Earnings Call
Positive tone
FDA Complete Response Letter for Simponi biosimilar
Biosimilar pipeline and development programs
Reykjavik facility inspection and remediation
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Alvotech Q2 FY2025 Earnings Call
Confident tone
Financial performance and growth
Humira biosimilar (SIMLANDI/HUKYNDRA)
STELARA biosimilar (AVT04)
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Alvotech Q1 FY2025 Earnings Call
Confident tone
Stelara biosimilar launch and interchangeable designation
Humira / SIMLANDI commercial performance
Capacity / manufacturing scale
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q3
2024-09-30
Alvotech Q3 FY2024 Earnings Call
Confident tone
Pipeline Advancement
2025 Revenue Guidance
FDA Inspection and Compliance
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Alvotech Q2 FY2024 Earnings Call
Confident tone
US Humira (adalimumab) biosimilar ramp
Pipeline expansion and upcoming submissions
Stelara biosimilar (SELARSDI / AVT04)
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Alvotech Q1 FY2024 Earnings Call
Confident tone
Humira biosimilar (AVT02) U.S. launch
Stelara biosimilar (AVT04/Selarsdi) global launches
Pipeline expansion and new filings
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Alvotech Q4 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Alvotech Q3 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Alvotech Q2 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Alvotech Q1 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Alvotech Q4 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Alvotech Q3 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Alvotech Q2 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–19 of 19 earnings calls
Key facts
CIK
1898416
CUSIP
L01800108
13F (30d)
74 filings
73 filers
Visit website
Investor relations